Maryland
|
001-14494
|
33-0724736
|
||
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
10 North Park Place, Suite 201
Morristown, NJ
|
07960
|
|
(Address of principal executive offices)
|
(Zip Code)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
PERNIX THERAPEUTICS HOLDINGS, INC.
|
|||
Dated: July 28, 2015
|
By:
|
/s/ Sanjay Patel
|
|
Sanjay Patel
|
|||
Chief Financial Officer
|
Exhibit Number
|
Exhibit Title
|
3.1
|
Articles of Amendment to the Articles of Incorporation of the Company.
|
PERNIX THERAPEUTICS HOLDINGS, INC.
|
|||
By:
|
/s/ Douglas L. Drysdale
|
||
Name: Douglas L. Drysdale
|
|||
Title: President
|
|||
ATTEST:
|
|||
By:
|
/s/ Barry J. Siegel
|
||
Name: Barry J. Siegel
|
|||
Title: Secretary
|
|||